Literature DB >> 18408130

VEGF promotes vascular sympathetic innervation.

Stephen B Marko1, Deborah H Damon.   

Abstract

The sympathetic nervous system, via postganglionic innervation of blood vessels and the heart, is an important determinant of cardiovascular function. The mechanisms underlying sympathetic innervation of targets are not fully understood. This study tests the hypothesis that target-derived vascular endothelial growth factor (VEGF) promotes sympathetic innervation of blood vessels. Western blot and immunohistochemical analyses indicate that VEGF is produced by vascular cells in arteries and that VEGF receptors are expressed on sympathetic nerve fibers innervating arteries. In vitro, exogenously added VEGF and VEGF produced by vascular smooth muscle cells (VSMCs) in sympathetic neurovascular cocultures inhibited semaphorin 3A (Sema3A)-induced collapse of sympathetic growth cones. In the absence of Sema3A, VEGF and VSMCs also increased growth cone area. These effects were mediated via VEGF receptor 1. In vivo, the neutralization of VEGF inhibited the reinnervation of denervated femoral arteries. These data demonstrate that target-derived VEGF plays a previously unrecognized role in promoting the growth of sympathetic axons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408130     DOI: 10.1152/ajpheart.00291.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  34 in total

1.  Vascular endothelial growth factor protects post-ganglionic sympathetic neurones from the detrimental effects of hydrogen peroxide by increasing catalase.

Authors:  D H Damon
Journal:  Acta Physiol (Oxf)       Date:  2011-03-14       Impact factor: 6.311

2.  Semaphorin 3A inhibits growth of adult sympathetic and parasympathetic neurones via distinct cyclic nucleotide signalling pathways.

Authors:  M R Nangle; J R Keast
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

3.  VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

Review 4.  Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus.

Authors:  Adilson Guilherme; Felipe Henriques; Alexander H Bedard; Michael P Czech
Journal:  Nat Rev Endocrinol       Date:  2019-04       Impact factor: 43.330

5.  Fetal cerebral oxygenation: the homeostatic role of vascular adaptations to hypoxic stress.

Authors:  William J Pearce; Stacy M Butler; Jenna M Abrassart; James M Williams
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

6.  Fast rearrangement of the neuronal growth cone's actin cytoskeleton following VEGF stimulation.

Authors:  Laura Olbrich; Daniel Foehring; Patrick Happel; Beate Brand-Saberi; Carsten Theiss
Journal:  Histochem Cell Biol       Date:  2012-10-04       Impact factor: 4.304

Review 7.  Role of the sympathetic autonomic nervous system in hypoxic remodeling of the fetal cerebral vasculature.

Authors:  Olayemi O Adeoye; Jinjutha Silpanisong; James M Williams; William J Pearce
Journal:  J Cardiovasc Pharmacol       Date:  2015-04       Impact factor: 3.105

8.  Neuropilin ligands in vascular and neuronal patterning.

Authors:  Alessandro Fantin; Charlotte H Maden; Christiana Ruhrberg
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

Review 9.  VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration.

Authors:  Peter Carmeliet; Carmen Ruiz de Almodovar; Ruiz de Almodovar Carmen
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

10.  Tissue-engineered dermo-epidermal skin analogs exhibit de novo formation of a near natural neurovascular link 10 weeks after transplantation.

Authors:  Thomas Biedermann; Agnieszka S Klar; Sophie Böttcher-Haberzeth; Clemens Schiestl; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2014-02       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.